![]() ![]() ![]() It began in earnest in the 1980s with Sir Iain Chalmers and the Cochrane Collaboration demanding more trial information from pharma and regulators, in order for doctors and researchers to better understand whether these medicines were safe and effective. This period marked a real turn in the transparency debate. Shortly after Bad Pharma was published - a book in which Dr Goldacre lambasted pharma and regulators over their lack of transparency - AllTrials was established by The BMJ, Sense About Science, Dr Goldacre and others, which began lobbying for all clinical trials to be registered and published. Since the publication of Dr Ben Goldacre's Bad Pharma book in 2012, the issue of clinical trial transparency has gone from being a piece of esoterica discussed in the halls of academia to a major public campaign. ![]()
0 Comments
Leave a Reply. |